psi-napse, established by the directors – Jill and Del Rasmussen – in 1994, is an independent consultancy specialising in advice on discovery and worldwide strategic development of CNS drugs, particularly for psychiatric and neurological disorders. The client base represents three major areas of activity:
- Pharma (small, medium and large)
- Due diligence for Venture Capital Investors
- Educational Initiatives
Although based in the UK, psi-napse has clients world-wide including continental Europe, North America and Japan as well as the UK.
Each of the directors has more than 20 years Pharma experience. In addition, Dr Jill Rasmussen maintains a part-time clinical commitment in the UK National Health Service (NHS).
psi-napse offers:
- Expertise from concept to commercialisation
- Continuing experience in “real world” clinical practice
- Exclusively personal service
- Maintain cutting edge expertise in CNS and drug development
- Loyalty to customers
The combination of expertise in strategic drug development and hands-on experience in the UK NHS brings a real-life perspective to the psi-napse consultancy.
psi-napse is a clinically and commercially aware, business-oriented consultancy with broad experience of world-wide drug development and medico-marketing in CNS indications. psi-napse has a proven ability to develop and exploit strategies that deliver drugs effectively to the market place.
© psi-napse 2006